Plain-English translation of NCT04296604 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcranial direct current stimulation (tDCS), a noninvasive procedure that uses mild electrical current to stimulate specific areas of the brain. The researchers want to see whether this treatment can improve executive function—your ability to focus, plan, and make decisions—in people with various neuropsychiatric conditions including traumatic brain injury, depression, bipolar disorder, schizophrenia, ADHD, borderline personality disorder, and substance use disorders. The study includes healthy volunteers for comparison.
Many people with these conditions struggle with executive function (focusing, planning, and decision-making), and current treatments don't always help enough. This trial is exploring whether noninvasive brain stimulation could be a new tool to improve these thinking skills.
You likely qualify if…
You likely don't qualify if…
You will attend three separate sessions where you receive transcranial direct current stimulation. Two of these sessions will be active treatment, and one will be a sham (placebo) session—neither you nor the researchers will know which is which until the study ends. During each session, electrodes will be placed on your scalp to deliver mild electrical current, and you'll complete cognitive tests to measure changes in your thinking and focus abilities. The total time commitment and number of visits will be explained during screening.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States